Who are Compound Ciwujia Granules, Guipi Granules's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/compound-ciwujia-granules-guipi-granules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Compound Ciwujia Granules, Guipi Granules — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compound Ciwujia Granules, Guipi Granules (Compound Ciwujia Granules, Guipi Granules) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / Traditional Chinese Medicine. Area: General wellness / Constitutional support.

marketed Herbal combination / Traditional Chinese Medicine General wellness / Constitutional support Small molecule Live · refreshed every 30 min

Target snapshot

Compound Ciwujia Granules, Guipi Granules (Compound Ciwujia Granules, Guipi Granules) — Heilongjiang Quanle Pharmaceutical Co., Ltd.. This is a combination of two traditional Chinese medicine herbal granules that work synergistically to tonify qi, nourish blood, and strengthen the spleen and heart.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Compound Ciwujia Granules, Guipi Granules TARGET	Compound Ciwujia Granules, Guipi Granules	Heilongjiang Quanle Pharmaceutical Co., Ltd.	marketed	Herbal combination / Traditional Chinese Medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / Traditional Chinese Medicine class)

Heilongjiang Quanle Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Compound Ciwujia Granules, Guipi Granules — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-ciwujia-granules-guipi-granules. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab